<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener('load', function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <div id="navbar-iframe-container"></div> <script type="text/javascript" src="https://apis.google.com/js/platform.js"></script> <script type="text/javascript"> gapi.load("gapi.iframes:gapi.iframes.style.bubble", function() { if (gapi.iframes && gapi.iframes.getContext) { gapi.iframes.getContext().openChild({ url: 'https://www.blogger.com/navbar/5621345630369022014?origin\x3dhttps://cderwn.blogspot.com', where: document.getElementById("navbar-iframe-container"), id: "navbar-iframe" }); } }); </script>

Drug Evaluation & Research

CDERNEW-TEXT 10/10/2007


Wednesday, October 10, 2007

October 9, 2007

BPCA/Pediatric Exclusivity Statistics:

Breakdown of Requested Studies Report
http://www.fda.gov/cder/pediatric/breakdown.htm

(updated)

Spectrum of Diseases/Conditions
http://www.fda.gov/cder/pediatric/specdis.htm

(updated)

Written Requests Issued http://www.fda.gov/cder/pediatric/wrlist.htm
(updated)

Written Requests Statistics
http://www.fda.gov/cder/pediatric/wrstats.htm

(updated)

CDER Organization Charts [HTML http://www.fda.gov/cder/cderorg.htm ]
[PDF http://www.fda.gov/cder/cderorg/cder-all.pdf ] (updated)

Current Drug Shortage

Solu-Cortef 100mg (Hydrocortisone sodium succinate) for injection
http://www.fda.gov/cder/drug/shortages/default.htm#Valstar

(updated)

Valstar (valrubicin) Solution for Intravesical Instillation
http://www.fda.gov/cder/whatsnew.htm#Valstar (updated)

New and Generic Drug Approvals
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm

Accutane (isotretinoin) Capsules, Hoffman La-Roche, Labeling Revision

Aptivus (tipranavir) Capsules, Boehringer Ingelheim Pharma, Accelerated
Approval

Cetirizine Hydrochloride Chewable Tablets, Caraco Pharma, Tentative
Approval

Estradiol Valerate Injection, Sandoz Inc., Approval

Granisetron Hydrochloride Injection, Abraxis Pharma, Tentative Approval

Hydrochlorothiazide Tablets, Apotex, Approval

Irinotecan Hydrochloride Injection, Abraxis Pharma, Tentative Approval

LEXXEL (enalapril maleate-felodipine ER) Tablets, AstraZeneca, Labeling
Revision

Nifedipine Extended-release Tablets, Osmotica Pharma, Approval

Qualaquin (quinine sulfate) Capsules, AR Holding Co., Labeling Revision

Sensipar (cinacalcet) Tablets, Amgen Inc., Labeling Revision

Torsemide Tablets, Apotex, Supplier Addition

Valacyclovir Hydrochloride Tablets, Teva Pharma, Tentative Approval

VUSION (miconazole nitrate, zinc oxide, white petrolatum) Ointment,
Barrier Therapeutics, Labeling Revision

Zestril (lisinopril) Tablets, AstraZeneca, Labeling Revision

Zestoretic (lisinopril/hctz) Tablets, AstraZeneca, Labeling Revision

Zoloft (sertraline hydrochloride) Tablets, Pfizer Pharma, Labeling
Revision

Zoloft (sertraline hydrochloride) Oral Concentrate, Pfizer Pharma,
Labeling Revision

------------------------------------------------
To subscribe or to unsubscribe from CDERNEW-TEXT

http://list.nih.gov/archives/cdernew-text.html
------------------------------------------------

posted by Mags @ 10:36 AM,




0 Comments:

Post a Comment

<< Home